Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 15;48(10):1364-71.
doi: 10.1086/598331.

Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis

Jay R McDonald  1 , Angelique L Zeringue, Liron Caplan, Prabha Ranganathan, Hong Xian, Thomas E Burroughs, Victoria J Fraser, Fran Cunningham, Seth A Eisen
Affiliations

Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis

Jay R McDonald et al. Clin Infect Dis. .

Abstract

Background: Herpes zoster occurs more commonly in patients taking immunosuppressive medications, although the risk associated with different medications is poorly understood.

Methods: We conducted a retrospective cohort study involving 20,357 patients who were followed in the Veterans Affairs healthcare system and treated for rheumatoid arthritis from October 1998 through June 2005. Cox proportional hazards regression was used to determine risk factors for herpes zoster and herpes zoster-free survival. Chart review was performed to validate the diagnosis of herpes zoster.

Results: The incidence of herpes zoster was 9.96 episodes per 1000 patient-years. In time-to-event analysis, patients receiving medications used to treat mild rheumatoid arthritis were less likely to have an episode of herpes zoster than patients receiving medications used to treat moderate and severe rheumatoid arthritis (P < .001). Independent risk factors for herpes zoster included older age, prednisone use, medications used to treat moderate and severe rheumatoid arthritis, malignancy, chronic lung disease, renal failure, and liver disease. Among patients receiving tumor necrosis factor-alpha antagonists, etanercept (hazard ratio, 0.62) and adalimumab (hazard ratio, 0.53) were associated with a lower risk of herpes zoster. There was excellent agreement between the International Classification of Diseases, Version 9, Clinical Modification diagnosis of herpes zoster and diagnosis by chart review (kappa = 0.92).

Conclusions: Risk factors for herpes zoster included older age, prednisone use, medications used to treat moderate and severe rheumatoid arthritis, and several comorbid medical conditions. These results demonstrate that the Department of Veterans Affairs' national administrative databases can be used to study rare adverse drug events.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study Flow Diagram.
Figure 2
Figure 2
After adjusting for demographic data and comorbid medical conditions, time-to-herpes zoster was different among groups 1, 2, and 3 (p<0.001).
See this image and copyright information in PMC

Comment in

References

    1. Wareham DW, Breuer J. Herpes zoster. BMJ. 2007;334:1211–1215. - PMC - PubMed
    1. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352:2266–2267. - PubMed
    1. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26–33. - PubMed
    1. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology. 2006;45:1370–1375. - PubMed
    1. Chidiac C, Bruxelle J, Daures J-P, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001;33:62–69. - PubMed

Publication types

Substances